Category
Description
It consists of human islets (n=5) treated with IFNγ + IL-1β with or without difluoromethylornithine (DFMO) and submitted to RNA-seq and proteomics analysis (Table 1). DFMO is an inhibitor of ornithine decarboxylase (ODC), an enzyme of the polyamine pathway. Therefore, this treatment was done to study if inhibiting the polyamine synthesis improves β-cell dysfunction.
Data repositories:
RNA-seq: GSE226888
Proteomics: MSV000091431
Publication: PMID 37918404
English